Alterations in the solubility and intracellular localization of parkin by several familial Parkinson's disease‐linked point mutations
暂无分享,去创建一个
K. Lim | T. Lim | T. Dawson | Michelle W L Ho | Jeanne M. M. Tan | Cheng Wang | Michelle Ho | N. Zaiden | S. Wong | Constance L C Chew | Pei Woon Eng | Constance L. C. Chew | Pei Woon Eng
[1] S. Shin,et al. Formation and removal of alpha-synuclein aggregates in cells exposed to mitochondrial inhibitors. , 2002, The Journal of biological chemistry.
[2] T. Dawson,et al. Molecular Pathways of Neurodegeneration in Parkinson's Disease , 2003, Science.
[3] N. Hattori,et al. An Unfolded Putative Transmembrane Polypeptide, which Can Lead to Endoplasmic Reticulum Stress, Is a Substrate of Parkin , 2001, Cell.
[4] T. Dawson,et al. Parkin functions as an E2-dependent ubiquitin- protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[5] John Q. Trojanowski,et al. Induction of α-Synuclein Aggregation by Intracellular Nitrative Insult , 2001, The Journal of Neuroscience.
[6] A. Abeliovich,et al. Parkin Is a Component of an SCF-like Ubiquitin Ligase Complex and Protects Postmitotic Neurons from Kainate Excitotoxicity , 2003, Neuron.
[7] R. Kopito,et al. Aggresomes, inclusion bodies and protein aggregation. , 2000, Trends in cell biology.
[8] C. Ross,et al. Parkin ubiquitinates the α-synuclein–interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease , 2001, Nature Medicine.
[9] M. Mouradian,et al. Parkin Accumulation in Aggresomes Due to Proteasome Impairment* , 2002, The Journal of Biological Chemistry.
[10] P. Lockhart,et al. Parkin genetics: one model for Parkinson's disease. , 2004, Human molecular genetics.
[11] C A Ross,et al. Synphilin‐1 is present in Lewy bodies in Parkinson's disease , 2000, Annals of neurology.
[12] K. Lim,et al. Molecular Mechanisms of Neurodegeneration in Parkinson's Disease: Clues from Mendelian Syndromes , 2003, IUBMB life.
[13] C. Pickart,et al. Mechanisms underlying ubiquitination. , 2001, Annual review of biochemistry.
[14] G. Scott,et al. Inhibition of proteasomal activity causes inclusion formation in neuronal and non-neuronal cells overexpressing Parkin. , 2003, Molecular biology of the cell.
[15] L. Seeberger,et al. Heterozygosity for a mutation in the parkin gene leads to later onset Parkinson disease , 2003, Neurology.
[16] J. Trojanowski,et al. Induction of alpha-synuclein aggregation by intracellular nitrative insult. , 2001, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[17] S. Minoshima,et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism , 1998, Nature.
[18] Bonifati,et al. Association between early-onset Parkinson's disease and mutations in the parkin gene. , 2000, The New England journal of medicine.
[19] Nobutaka Hattori,et al. Ubiquitination of a New Form of α-Synuclein by Parkin from Human Brain: Implications for Parkinson's Disease , 2001, Science.
[20] M. Ruberg,et al. The C289G and C418R missense mutations cause rapid sequestration of human Parkin into insoluble aggregates , 2003, Neurobiology of Disease.
[21] P. Bork,et al. A novel transactivation domain in parkin. , 1999, Trends in biochemical sciences.
[22] Jian Feng,et al. Parkin is recruited to the centrosome in response to inhibition of proteasomes , 2003, Journal of Cell Science.
[23] Y. Imai,et al. Parkin Suppresses Unfolded Protein Stress-induced Cell Death through Its E3 Ubiquitin-protein Ligase Activity* , 2000, The Journal of Biological Chemistry.
[24] P. Lockhart,et al. RING finger 1 mutations in Parkin produce altered localization of the protein. , 2003, Human molecular genetics.
[25] K. Winklhofer,et al. Inactivation of Parkin by Oxidative Stress and C-terminal Truncations , 2003, Journal of Biological Chemistry.
[26] Jean-François Deleuze,et al. Complex relationship between Parkin mutations and Parkinson disease. , 2002, American journal of medical genetics.
[27] S. Shin,et al. Formation and Removal of α-Synuclein Aggregates in Cells Exposed to Mitochondrial Inhibitors* , 2002, The Journal of Biological Chemistry.
[28] N. Wood,et al. Parkin is recruited into aggresomes in a stress-specific manner: over-expression of parkin reduces aggresome formation but can be dissociated from parkin's effect on neuronal survival. , 2003, Human molecular genetics.
[29] Ping Wang,et al. Structure of a c-Cbl–UbcH7 Complex RING Domain Function in Ubiquitin-Protein Ligases , 2000, Cell.
[30] L. Pallanck,et al. Parkin A Multipurpose Neuroprotective Agent? , 2003, Neuron.
[31] P. Lockhart,et al. Functional association of the parkin gene promoter with idiopathic Parkinson's disease. , 2002, Human molecular genetics.
[32] D. Hernandez,et al. Lewy bodies and parkinsonism in families with parkin mutations , 2001, Annals of neurology.
[33] Shinsei Minoshima,et al. Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase , 2000, Nature Genetics.